Amid Hydroxychloroquine Uproar, Real Studies of Drug Are Suffering (New York Times, quotes Christine Johnston)

President Trump’s enthusiastic embrace of a malaria drug that he now says he takes daily — and the resulting uproar in the news media — appears to be interfering with legitimate scientific research into whether the medicine might work to prevent coronavirus infection or treat the disease in its early stages.

UW to Lead National Study of Drug Promoted by President Trump to Fight Coronavirus (Seattle Times, Includes Ruanne Barnabas)

Researchers at the University of Washington on Friday announced a major new study of the malaria drug President Donald Trump has praised as a possible, low-cost cure for COVID-19.

The clinical trial is one of dozens around the world aimed at providing definitive evidence about the effectiveness of hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, against the novel coronavirus.